Articles related to ALZHEIMER'S/DEMENTIA

More than half of adult Americans (60%) have at least one chronic condition that eventually lead to disability, mortality, and reduced quality of life. And chronic conditions account for 90% of America’s $3.8 trillion in annual healthcare costs. The CDC says these are the eight most expensive.

According to Daniel A. Nation, PhD, associate professor of psychological science at University of California, Irvine: “Studies of angiotensin II receptor blockers and ACE inhibitors have suggested these medicines may confer the greatest benefit to long-term cognition, while other studies have shown the benefits of calcium channel blockers and diuretics on reducing dementia risk.”

We’ve all experienced a memory blip now and then, but these so-called “senior moments” could actually be signaling a bigger problem. Alzheimer’s disease (AD) is not a normal part of aging even though aging ups the risk for developing the condition. Here are 10 warning signs you can share with patients if they’re questioning what’s normal memory behavior and what’s not.  

MedPage Today presents this illuminating conversation with Daniel Gibbs, MD, PhD, a retired neurologist and author of the book, A Tattoo on my Brain: A Neurologist’s Personal Battle against Alzheimer’s Disease. In the question-and-answer session, Dr. Gibbs discusses his early diagnosis, his participation in clinical trials, and his experiences and unique perspectives as a neurologist with the disease.

In this MedPage Today interview with Jason Karlawish, MD, co-director of the Penn Memory Center at the University of Pennsylvania in Philadelphia and author of the new book, The Problem of Alzheimer’s: How Science, Culture, and Politics Turned a Rare Disease Into a Crisis and What We Can Do About It, the  biomarker “revolution” is discussed, along with the discovery of the idea of mild cognitive impairment.